Sign Up to like & get
recommendations!
1
Published in 2019 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2019.1627323
Abstract: ABSTRACT Introduction: The recent approval of monoclonal antibodies targeting the calcitonin gene-related peptide (CGRP) pathway introduced the first preventive treatments for migraine that were specifically designed to target the underlying pathophysiology of the disease. Fremanezumab,…
read more here.
Keywords:
migraine;
treatment migraine;
preventive treatments;
migraine fremanezumab ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Expert Review of Neurotherapeutics"
DOI: 10.1080/14737175.2019.1614742
Abstract: ABSTRACT Introduction: The importance of calcitonin gene-related peptide (CGRP) in migraine pathogenesis is well established. Fremanezumab is a humanized IgG2a monoclonal antibody that binds to CGRP. Areas covered: In this paper, we review the development…
read more here.
Keywords:
migraine;
treatment episodic;
episodic chronic;
fremanezumab preventive ... See more keywords